Verified peer comparison
GT Biopharma vs Evommune Financial Comparison
Direct answer
GT Biopharma and Evommune are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- GT Biopharma Revenue
- 0 USD
- Evommune Revenue
- 13,000,000 USD
- GT Biopharma Operating income
- -12,422,000 USD
- Evommune Operating income
- -81,071,000 USD